Effects of scopolamine on delayed-matching-to-sample and paired associates tests of visual memory and learning in human subjects: comparison with diazepam and implications for dementia
- PMID: 9399372
- DOI: 10.1007/s002130050430
Effects of scopolamine on delayed-matching-to-sample and paired associates tests of visual memory and learning in human subjects: comparison with diazepam and implications for dementia
Abstract
Two experiments examined dose-related effects of 200, 400 and 600 micrograms scopolamine (n = 24, s.c.) and 5 and 10 mg diazepam (n = 6, PO) on parallel tests of visual memory and learning taken from the CANTAB battery. Scopolamine significantly impaired accuracy of performance on a delayed matching to sample test of visual recognition memory in a dose- and delay-dependent manner, but had only marginal decremental effects on a test of visuospatial paired associates learning. Scopolamine significantly lengthened decision times in a visual search matching to sample task at the 400 and 600 micrograms doses, without significantly affecting accuracy. The drug also impaired performance on tests of spatial (on accuracy and response time measures) and pattern (on response time only) memory. Most of the deleterious effects on scopolamine were removed by covariance analyses with indices of subjective sedation, but the effects of delayed matching accuracy and latency remained. By contrast, diazepam significantly impaired paired associates learning but affected delayed matching to sample in a delay-independent manner. These results suggest that scopolamine can produce selective deficits in tests of short-term visual recognition memory which do not depend on overall impairments in arousal and which contrast with deficits in visual associative learning produced by diazepam. They have implications for the pharmacological modelling of dementia and memory disorders in man and for the neurochemical substrates of the short-term recognition memory and associative learning for visual stimuli.
Similar articles
-
Effects of scopolamine on matching to sample paradigm and related tests in human subjects.Neuropsychobiology. 2003;48(2):87-94. doi: 10.1159/000072883. Neuropsychobiology. 2003. PMID: 14504417 Clinical Trial.
-
Dissociation of cholinergic function in spatial and procedural learning in rats.Neuroscience. 2007 May 25;146(3):875-89. doi: 10.1016/j.neuroscience.2007.02.038. Epub 2007 Apr 6. Neuroscience. 2007. PMID: 17418958
-
Modulation of spatial alternation and anxiety by septal scopolamine systemic diazepam in mice.Pharmacol Biochem Behav. 1998 Jul;60(3):733-8. doi: 10.1016/s0091-3057(98)00035-5. Pharmacol Biochem Behav. 1998. PMID: 9678658
-
Beyond the blur: Scopolamine's utility and limits in modeling cognitive disorders across sexes - Narrative review.Ageing Res Rev. 2025 Feb;104:102635. doi: 10.1016/j.arr.2024.102635. Epub 2024 Dec 7. Ageing Res Rev. 2025. PMID: 39653154 Review.
-
Commentary on mood and memory.Behav Res Ther. 1987;25(6):443-55. doi: 10.1016/0005-7967(87)90052-0. Behav Res Ther. 1987. PMID: 3322254 Review. No abstract available.
Cited by
-
Modulation of memory and visuospatial processes by biperiden and rivastigmine in elderly healthy subjects.Psychopharmacology (Berl). 2005 Sep;181(3):582-94. doi: 10.1007/s00213-005-0083-7. Epub 2005 Oct 12. Psychopharmacology (Berl). 2005. PMID: 16041534 Clinical Trial.
-
Neuropsychological performance in young adults with cannabis use disorder.J Psychopharmacol. 2021 Nov;35(11):1349-1355. doi: 10.1177/02698811211050548. Epub 2021 Oct 25. J Psychopharmacol. 2021. PMID: 34694178 Free PMC article.
-
Cholinergic modulation of visual attention and working memory: dissociable effects of basal forebrain 192-IgG-saporin lesions and intraprefrontal infusions of scopolamine.Learn Mem. 2004 Jan-Feb;11(1):78-86. doi: 10.1101/lm.70904. Learn Mem. 2004. PMID: 14747520 Free PMC article.
-
Cholinergic nicotinic systems in Alzheimer's disease: prospects for pharmacological intervention.CNS Drugs. 2002;16(7):485-500. doi: 10.2165/00023210-200216070-00005. CNS Drugs. 2002. PMID: 12056923
-
Cognitive performance and cholinergic transmission: influence of muscarinic and nicotinic receptor blockade.Eur Arch Psychiatry Clin Neurosci. 2010 Nov;260 Suppl 2:S106-10. doi: 10.1007/s00406-010-0160-8. Epub 2010 Oct 20. Eur Arch Psychiatry Clin Neurosci. 2010. PMID: 20960003 Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources